Evidence map›Paper›PMID 28230789›Full record

ReviewToxins2017

Fungal Ribotoxins: A Review of Potential Biotechnological Applications.

Miriam Olombrada, Rodrigo Lázaro-Gorines, Juan C López-Rodríguez, Álvaro Martínez-Del-Pozo, Mercedes Oñaderra, Moisés Maestro-López, Javier Lacadena, José G Gavilanes, Lucía García-Ortega

Open access · goldAbstract readReview
In one paragraph

Review in Toxins, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 79 citations in OpenAlex.

  1. Article
  2. Article
  3. Dynamic proteomic changes and ultrastructural insights intoFrontiers in cellular and infection microbiology · 2025
    Article
  4. mBio · 2024
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. The Entomopathogenic FungusJournal of fungi (Basel, Switzerland) · 2022
    Article
  19. The Secreted Ribonuclease SRE1 Contributes toFrontiers in microbiology · 2022
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 2 countries.

Miriam OlombradaDepartamento de Bioquímica y Biología Molecular I, Facultad de Química, Universidad Complutense de Madrid, 28040 Madrid, Spain. miriam.olombrada@ieu.uzh.ch.
Rodrigo Lázaro-GorinesDepartamento de Bioquímica y Biología Molecular I, Facultad de Química, Universidad Complutense de Madrid, 28040 Madrid, Spain. rodrigolazarogorines@ucm.es.
Juan C López-RodríguezDepartamento de Bioquímica y Biología Molecular I, Facultad de Química, Universidad Complutense de Madrid, 28040 Madrid, Spain. jc.lopez@ucm.es.
Álvaro Martínez-Del-PozoDepartamento de Bioquímica y Biología Molecular I, Facultad de Química, Universidad Complutense de Madrid, 28040 Madrid, Spain. alvaromp@quim.ucm.es.
Mercedes OñaderraDepartamento de Bioquímica y Biología Molecular I, Facultad de Química, Universidad Complutense de Madrid, 28040 Madrid, Spain. monaderr@bio.ucm.es.
Moisés Maestro-LópezDepartamento de Bioquímica y Biología Molecular I, Facultad de Química, Universidad Complutense de Madrid, 28040 Madrid, Spain. moisesmaes@gmail.com.
Javier LacadenaDepartamento de Bioquímica y Biología Molecular I, Facultad de Química, Universidad Complutense de Madrid, 28040 Madrid, Spain. jlacadena@quim.ucm.es.
José G GavilanesDepartamento de Bioquímica y Biología Molecular I, Facultad de Química, Universidad Complutense de Madrid, 28040 Madrid, Spain. jggavila@ucm.es.
Lucía García-OrtegaDepartamento de Bioquímica y Biología Molecular I, Facultad de Química, Universidad Complutense de Madrid, 28040 Madrid, Spain. luciagar@ucm.es.
Universidad Complutense de Madrid · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fungi establish a complex network of biological interactions with other organisms in nature. In many cases, these involve the production of toxins for survival or colonization purposes. Among these toxins, ribotoxins stand out as promising candidates for their use in biotechnological applications. They constitute a group of highly specific extracellular ribonucleases that target a universally conserved sequence of RNA in the ribosome, the sarcin-ricin loop. The detailed molecular study of this family of toxic proteins over the past decades has highlighted their potential in applied research. Remarkable examples would be the recent studies in the field of cancer research with promising results involving ribotoxin-based immunotoxins. On the other hand, some ribotoxin-producer fungi have already been studied in the control of insect pests. The recent role of ribotoxins as insecticides could allow their employment in formulas and even as baculovirus-based biopesticides. Moreover, considering the important role of their target in the ribosome, they can be used as tools to study how ribosome biogenesis is regulated and, eventually, may contribute to a better understanding of some ribosomopathies.

Indexed as

Fungal ProteinsMycotoxinsRibonucleasesAnimalsBiotechnologyFungiHumansRibosomesFungal ProteinsMycotoxinsRibonucleasesbiopesticidecancerfungal ribotoxinsimmunotoxininsecticideribonuclease (RNase)ribosomeribosomopathiessarcin-ricin loop (SRL)

Identifiers

PMID28230789
PMCPMC5331450
OpenAlexW2591266398

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.